Olema raises $209m for IPO

San Francisco-based Olema, a biopharmaceutical company focused on women’s cancers, has raised $209 million for its IPO after pricing its 11 million shares at $19 per share.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this